Naturalistic follow-up of youths treated for pediatric anxiety disorders

JAMA Psychiatry

Volumn 71, Issue 3, 2014, Pages 310-318

  Ginsburg, Golda S ^a   Becker, Emily M ^b   Keeton, Courtney P ^a   Sakolsky, Dara ^c   Piacentini, John ^d   Albano, Anne Marie ^e   Compton, Scott N ^f   Iyengar, Satish ^c   Sullivan, Kevin ^f   Caporino, Nicole ^g   Peris, Tara ^d   Birmaher, Boris ^c   Rynn, Moira ^e   March, John ^f   Kendall, Philip C ^g  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NewYork Presbyterian Hospital   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g TEMPLE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SERTRALINE;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; BRIEF SYMPTOM INVENTORY; CHILD; CHILD ADOLESCENT ANXIETY MULTIMODAL EXTENDED LONG TERM STUDY; CHILD ADOLESCENT ANXIETY MULTIMODAL STUDY; CHILD PSYCHIATRY; CLINICAL GLOBAL IMPRESSION SCALE; COGNITIVE THERAPY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DSM-IV; FAMILY FUNCTIONING; FEMALE; FOLLOW UP; HUMAN; LIFE EVENTS SCALE; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; MENTAL HEALTH SERVICE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OUTCOME ASSESSMENT; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCHOOL CHILD; SEMI STRUCTURED INTERVIEW; SEX DIFFERENCE; STATE TRAIT ANXIETY INVENTORY;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; CHILD; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; PLACEBOS; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84896781069     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2013.4186     Document Type: Article

References (28)

1. Buckner JD, Schmidt NB. Marijuana effect expectancies: relations to social anxiety and marijuana use problems. Addict Behav. 2008;33(11):1477-1483.
2. Kessler RC, Green JG, Gruber M, et al. The National Comorbidity Survey Adolescent Supplement (NCS-A), III: concordance of DSMIV/CIDI diagnoses with clinical reassessments. J AmAcad Child Adolesc Psychiatry. 2009;48:386-399.
3. Merikangas KR, He JP, BursteinM, et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010;49(10):980-989.
4. Walkup JT, Albano AM, Piacentini J, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med. 2008;359(26):2753-2766.
5. Kendall PC, Safford S, Flannery-Schroeder E, Webb A. Child anxiety treatment: outcomes in adolescence and impact on substance use and depression at 7.4-year follow-up. J Consult Clin Psychol. 2004;72(2):276-287.
6. Costello EJ, Egger HL, Angold A. The developmental epidemiology of anxiety disorders: phenomenology, prevalence, and comorbidity Child Adolesc Psychiatr Clin N Am. 2005;14(4):631-648, 7.
7. Kendall PC, Hedtke K. Cognitive-Behavioral Therapy for Anxious Children: Therapist Manual. 3rd ed. Ardmore, PA:Workbook Publishing; 2006.
8. Compton SN,Walkup JT, Albano AM, et al. Rationale, design, and methods of the Child/Adolescent Anxiety Multimodal Study (CAMS). Child Adolesc Psychiatry Ment Health. 2010;4:1-15.
9. Ginsburg GS, Kendall PC, Sakolsky D, et al. Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS. J Consult Clin Psychol. 2011;79(6): 806-813.
10. Kendall PC, Compton SN,Walkup JT, et al. Clinical characteristics of anxiety disordered youth. J Anxiety Disord. 2010;24(3):360-365.
11. Albano AM, Silverman WK. Clinician's Guide to the Anxiety Disorders Interview Schedule for DSM-IV, Child and Parent Versions. New York, NY: Oxford University Press; 2006.
12. GuyW. ECDEU Assessment Manual for Psychopharmacology-Revised. Rockville, MD: US Dept of Health, Education, andWelfare; 1976:218-222. DHEW publication ADM 76-338.
13. Shaffer D, GouldMS, Brasic J, et al. A Children's Global Assessment Scale (CGAS). Arch Gen Psychiatry. 1983;40(11):1228-1231.
14. Skinner H, Steinhauer P, Santa-Barbara J. Family Assessment Measure-III (FAM-III). North Tonawanda, NY: Multi-Health Systems; 1995.
15. Derogatis LR, Melisaratos N. The Brief Symptom Inventory: an introductory report. Psychol Med. 1983;13(3):595-605.
16. Spielberger CD. State-Trait Anxiety Inventory: Bibliography. 2nd ed. Palo Alto, CA: Consulting Psychologists Press; 1989.
17. Coddington RD. The significance of life events as etiologic factors in the diseases of children, II: a study of a normal population. J Psychosom Res. 1972;16(3):205-213.
18. Graham JW, Olchowski AE, Gilreath TD. How many imputations are really needed? Some practical clarifications of multiple imputation theory. Prev Sci. 2007;8(3):206-213.
19. Enders CK. AppliedMissing Data Analysis. New York, NY: Guilford Press; 2010.
20. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: J. Wiley & Sons; 1987.
21. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates, Publishers; 1988.
22. Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav ResMethods. 2007;39(2):175-191.
23. Cook EH,Wagner KD, March JS, et al. Long-term sertraline treatment of children and adolescents with obsessive-compulsive disorder. J AmAcad Child Adolesc Psychiatry. 2001;40(10):1175-1181.
24. Clark DB, Birmaher B, Axelson D, et al. Fluoxetine for the treatment of childhood anxiety disorders: open-label, long-term extension to a controlled trial. J AmAcad Child Adolesc Psychiatry. 2005;44(12):1263-1270.
25. M?tberg E, Clark DM, Bejerot S. Intensive group cognitive therapy and individual cognitive therapy for social phobia: sustained improvement at 5-year follow-up. J Anxiety Disord. 2011;25(8):994-1000.
26. Curry J, Silva S, Rohde P, et al. Recovery and recurrence following treatment for adolescent major depression. Arch Gen Psychiatry. 2011;68(3):263-269.
27. Bradley RH, Convyn RF, Burchinal M, McAdoo HP, Coll CG. The home environments of children in the United States, II: relations with behavioral development through age thirteen. Child Dev. 2001;72(6):1868-1886.
28. Caspi A, Henry B,McGee RO, Moffitt TE, Silva PA. Temperamental origins of child and adolescent behavior problems: from age three to age fifteen. Child Dev. 1995;66(1):55-68.